# Chronic Obstructive Pulmonary Disease as an Independent Predictor of Left Main Coronary Artery Disease

**Authors:** Beatrice Ragnoli, Carlotta Bertelegni, Leonardo Brugiatelli, Tarsi Giovanni, Fausto Chiazza, Mario Malerba

PMC · DOI: 10.3390/medsci14010131 · 2026-03-11

## TL;DR

This study shows that COPD patients are more likely to have severe left main coronary artery disease, even when overall heart disease is similar to non-COPD patients.

## Contribution

COPD is identified as an independent predictor of left main coronary artery disease, revealing a distinct coronary risk pattern.

## Key findings

- COPD patients had a significantly higher prevalence of left main coronary artery disease compared to non-COPD patients.
- Multivariable analysis confirmed COPD as an independent predictor of left main coronary artery disease.
- Small-caliber coronary branches were less commonly involved in COPD patients compared to intermediate-caliber vessels.

## Abstract

Background: Chronic obstructive pulmonary disease (COPD) is increasingly recognized as a disorder linked to increased cardiovascular risk, often coexisting with coronary artery disease (CAD), yet angiographic data on coronary involvement in COPD remain limited. This study aimed to evaluate whether COPD is associated with a distinct angiographic pattern of CAD, focusing on vessel distribution. Methods: We retrospectively enrolled 94 patients who underwent coronary angiography between 2023 and 2024 for suspected or known CAD. Clinical data, comorbidities, laboratory testing, pulmonary function, electrocardiography, echocardiography, and angiography were collected. Participants were stratified into two groups: COPD (n = 47) and non-COPD (n = 47). Coronary vessels were classified by number, location, and diameter. The normality of continuous variables was assessed using the Shapiro–Wilk test. Non-normally distributed variables were compared using the Mann–Whitney U test, while Fisher’s exact test was used for categorical comparisons. A multivariable logistic regression model was performed to identify independent predictors of left main coronary artery (LMCA) disease at the patient level. The primary endpoint was the association between COPD and CAD severity. Results: Baseline characteristics, including age, sex, BMI, and smoking history, were comparable between groups. The overall extent of CAD, expressed as the number of diseased vessels, did not differ significantly (p = 0.1436). However, vessel-based analysis revealed a distinct pattern: COPD patients showed a significantly higher prevalence of left main coronary artery (LMCA) disease compared to non-COPD patients (14% vs. 4.7%, p < 0.001). At the patient level, LMCA disease was present in 15/47 (31.9%) COPD patients compared with 6/47 (12.8%) non-COPD patients (p = 0.046). Multivariable logistic regression confirmed that COPD was an independent predictor of LMCA disease (OR = 3.56, 95% CI: 1.12–11.29, p = 0.031) after adjustment for age, sex, smoking, diabetes, and chronic kidney disease. Intermediate-caliber vessels were most frequently affected in both groups, while small-caliber branches were less commonly involved in COPD patients. Conclusions: COPD is an independent predictor of LMCA disease despite a similar overall angiographic extent of CAD. These findings suggest a distinct, high-risk coronary phenotype in COPD and highlight the need for enhanced cardiovascular vigilance and integrated cardiopulmonary management in this population.

## Linked entities

- **Diseases:** Chronic obstructive pulmonary disease (MONDO:0005002), coronary artery disease (MONDO:0005010), diabetes (MONDO:0005015), chronic kidney disease (MONDO:0005300)

## Full-text entities

- **Genes:** REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}
- **Diseases:** Cardiovascular Comorbidity (MESH:D002318), multi-vessel stenosis (MESH:D003251), two-vessel disease (MESH:D058529), left anterior descending artery disease (MESH:D020759), coronary involvement (MESH:D003323), GOLD 3-4 disease (OMIM:608392), Diabetes mellitus (MESH:D003920), COPD (MESH:D029424), atherogenic (MESH:D050197), ISCHEMIA (MESH:D007511), myocardial injury (MESH:D009202), Lung hyperinflation (MESH:D008171), dyspnea (MESH:D004417), non-ST Elevation Myocardial Infarction (MESH:D000072658), LMCA (MESH:D003324), GOLD stage 1-2 disease (MESH:D007676), NSTEMI (MESH:D000072657), dyslipidemia (MESH:D050171), peripheral arterial disease (MESH:D058729), ACS (MESH:D054058), injury to (MESH:D014947), unstable angina (MESH:D000789), PDA (MESH:D004374), death (MESH:D003643), Obesity (MESH:D009765), vascular damage (MESH:D057772), CHF (MESH:D006333), hypertension (MESH:D006973), respiratory impairment (MESH:D012131), Hyperuricemia (MESH:D033461), ischemic heart disease (MESH:D017202), Chronic kidney disease (MESH:D051436), endothelial dysfunction (MESH:D014652), single-vessel disease (MESH:D012640), inflammation (MESH:D007249), ischemic (MESH:D002545), CKD (MESH:D012080), cerebrovascular disease (MESH:D002561), myocardial infarction (MESH:D009203), FA (MESH:C565561), three-vessel disease (MESH:C536223), atrial fibrillation (MESH:D001281), hypoxemia (MESH:D000860), coronary disease (MESH:D003327)
- **Chemicals:** heparin (MESH:D006493), metoprolol (MESH:D008790), lipid (MESH:D008055), rosuvastatin (MESH:D000068718), LDL-C (-), nitric oxide (MESH:D009569), bisoprolol (MESH:D017298), atorvastatin (MESH:D000069059), enoxaparin (MESH:D017984), uric acid (MESH:D014527)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13027644/full.md

---
Source: https://tomesphere.com/paper/PMC13027644